HMG-CoA reductase inhibitors regulate TGF-B1 expression in human monocytes, endothelial cells and vascular smooth muscle cells

被引：0
|
作者：
Agah, R [1 ]
Spackman, T [1 ]
Cody, M [1 ]
机构：
[1] Univ Utah, Salt Lake City, UT USA
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2003年 / 23卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P327
引用
收藏
页码：A57 / A57
页数：1
相关论文
共 50 条
  • [31] The HMG-COA reductase inhibitor atorvastatin reduces FN14 expression induced by proinflammatory cytokines in human vascular smooth muscle cells
    Blanco-Colio, LM
    Munoz-Garcia, B
    Martin-Ventura, JL
    Martinez, E
    Hernandez, G
    Egido, J
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 3 - 3
  • [32] LDL-Induced Impairment of Human Vascular Smooth Muscle Cells Repair Function Is Reversed by HMG-CoA Reductase Inhibition
    Padro, Teresa
    Lugano, Roberta
    Garcia-Arguinzonis, Maisa
    Badimon, Lina
    PLOS ONE, 2012, 7 (06):
  • [33] HMG-CoA reductase inhibitors prevent migration of human coronary smooth muscle cells through suppression of increase in oxidative stress
    Yasunari, K
    Maeda, K
    Minami, M
    Yoshikawa, J
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (06) : 937 - 942
  • [34] Effect of HMG-CoA Reductase Inhibition on Vascular Smooth Muscle Cells Extracellular Matrix Production: Role of RhoA
    Palomino-Morales, Rogelio
    Perales, Sonia
    Torres, Carolina
    Linares, Ana
    Alejandre, Maria J.
    CURRENT VASCULAR PHARMACOLOGY, 2016, 14 (04) : 345 - 352
  • [35] Direct effect of HMG-CoA reductase inhibitors to human endothelial cells and on angiogenesis depends on kinds of statin
    Shingu, T.
    Katsumoto, M.
    Nomura, S.
    Nakata, A.
    Kuwashima, R.
    Chayama, K.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 191 - 191
  • [36] Inhibition of migration and proliferation of rat vascular smooth muscle cells by a new HMG-CoA reductase inhibitor, pitavastatin
    Kohno, M
    Shinomiya, K
    Abe, S
    Noma, T
    Kondo, I
    Oshita, A
    Takeuchi, H
    Takagi, Y
    Yukiiri, K
    Mizushige, K
    Ohmori, K
    HYPERTENSION RESEARCH, 2002, 25 (02) : 279 - 285
  • [37] Biphasic effect of HMG-CoA reductase inhibitor, pitavastatin, on vascular endothelial cells and angiogenesis
    Katsumoto, M
    Shingu, T
    Kuwashima, R
    Nakata, A
    Nomura, S
    Chayama, K
    CIRCULATION JOURNAL, 2005, 69 (12) : 1547 - 1555
  • [38] HMG-CoA reductase inhibitors inhibit human vascular smooth muscle cell calcification - Another pleiotropic effect of statins
    Son, B
    Iijima, K
    Kozaki, K
    Watanabe, T
    Ohike, Y
    Kojima, T
    Yu, J
    Miyahara, Y
    Ouchi, Y
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 213 - 213
  • [39] HMG-CoA reductase inhibitors: Role in normal and malignant cells
    Larsson, O
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 1996, 22 (03) : 197 - 212
  • [40] The effects of HMG-CoA reductase inhibitor on vascular progenitor cells
    Kusuyama, Takanori
    Omura, Takashi
    Nishiya, Daisuke
    Enomoto, Soichiro
    Matsumoto, Ryo
    Murata, Takashi
    Takeuchi, Kazuhide
    Yoshikawa, Junichi
    Yoshiyama, Minoru
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 101 (04) : 344 - 349
12345